Cu-DHM nanozymes treat flap ischemia-reperfusion injury by amplifying immune modulation in a cascade manner and inhibiting cell apoptosis
Flap ischemia-reperfusion (I/R) injury triggers intense inflammatory responses and oxidative stress following blood flow restoration, often resulting in tissue dysfunction. Currently, no effective and widely recognized treatment strategies are available in clinical practice. During flap I/R injury,...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2025-09-01
|
| Series: | Bioactive Materials |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2452199X25002725 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849249533788160000 |
|---|---|
| author | Xinyu Zhao Shuo Zhang Min Wang Qingrong Li Xiaolong Wei Xu-Lin Chen Xianwen Wang |
| author_facet | Xinyu Zhao Shuo Zhang Min Wang Qingrong Li Xiaolong Wei Xu-Lin Chen Xianwen Wang |
| author_sort | Xinyu Zhao |
| collection | DOAJ |
| description | Flap ischemia-reperfusion (I/R) injury triggers intense inflammatory responses and oxidative stress following blood flow restoration, often resulting in tissue dysfunction. Currently, no effective and widely recognized treatment strategies are available in clinical practice. During flap I/R injury, macrophages, T cells, and neutrophils form a complex regulatory network that jointly participates in inflammatory responses, immune modulation, and tissue repair. Achieving a dynamic balance among these three cell types is critical for flap survival and healing. In this study, a novel Cu-DHM NP metal-polyphenol nanozyme that effectively amplifies immune modulation in a cascade manner, inhibits apoptosis, and treats flap I/R injury was developed. Leveraging their excellent antioxidant properties and SOD-like and CAT-like enzyme activities, Cu-DHM NPs eliminate ROS, alleviate intracellular oxidative stress, protect mitochondrial function, and reduce apoptosis. Moreover, Cu-DHM NPs can regulate the immune microenvironment, cascade and amplify the immunomodulatory effect between macrophages and Naive CD4+ T cells, increase the proportions of M2 macrophages and Treg cells, and alleviate inflammation. In animal experiments, Cu-DHM NPs downregulated several pathways associated with inflammation and cell death. Cu-DHM NPs inhibited apoptosis, reduced neutrophil infiltration, alleviated inflammation, enhanced angiogenesis, and ultimately improved flap survival rates. This novel metal-polyphenol nanozyme offers a new strategy for treating flap I/R injury by increasing immune modulation and inhibiting apoptosis. |
| format | Article |
| id | doaj-art-9c2b2291adf247bcbaaaa683f69d5261 |
| institution | Kabale University |
| issn | 2452-199X |
| language | English |
| publishDate | 2025-09-01 |
| publisher | KeAi Communications Co., Ltd. |
| record_format | Article |
| series | Bioactive Materials |
| spelling | doaj-art-9c2b2291adf247bcbaaaa683f69d52612025-08-20T03:57:31ZengKeAi Communications Co., Ltd.Bioactive Materials2452-199X2025-09-015172073910.1016/j.bioactmat.2025.06.036Cu-DHM nanozymes treat flap ischemia-reperfusion injury by amplifying immune modulation in a cascade manner and inhibiting cell apoptosisXinyu Zhao0Shuo Zhang1Min Wang2Qingrong Li3Xiaolong Wei4Xu-Lin Chen5Xianwen Wang6Department of Burns, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, PR ChinaDepartment of Burns, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, PR ChinaSchool of Biomedical Engineering, Anhui Medical University, Hefei, 230032, PR ChinaSchool of Biomedical Engineering, Anhui Medical University, Hefei, 230032, PR ChinaSchool of Biomedical Engineering, Anhui Medical University, Hefei, 230032, PR ChinaDepartment of Burns, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, PR China; Corresponding author.Department of Burns, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, PR China; School of Biomedical Engineering, Anhui Medical University, Hefei, 230032, PR China; Corresponding author. Department of Burns, The First Affiliated Hospital of Anhui Medical University, Hefei 230032, PR China.Flap ischemia-reperfusion (I/R) injury triggers intense inflammatory responses and oxidative stress following blood flow restoration, often resulting in tissue dysfunction. Currently, no effective and widely recognized treatment strategies are available in clinical practice. During flap I/R injury, macrophages, T cells, and neutrophils form a complex regulatory network that jointly participates in inflammatory responses, immune modulation, and tissue repair. Achieving a dynamic balance among these three cell types is critical for flap survival and healing. In this study, a novel Cu-DHM NP metal-polyphenol nanozyme that effectively amplifies immune modulation in a cascade manner, inhibits apoptosis, and treats flap I/R injury was developed. Leveraging their excellent antioxidant properties and SOD-like and CAT-like enzyme activities, Cu-DHM NPs eliminate ROS, alleviate intracellular oxidative stress, protect mitochondrial function, and reduce apoptosis. Moreover, Cu-DHM NPs can regulate the immune microenvironment, cascade and amplify the immunomodulatory effect between macrophages and Naive CD4+ T cells, increase the proportions of M2 macrophages and Treg cells, and alleviate inflammation. In animal experiments, Cu-DHM NPs downregulated several pathways associated with inflammation and cell death. Cu-DHM NPs inhibited apoptosis, reduced neutrophil infiltration, alleviated inflammation, enhanced angiogenesis, and ultimately improved flap survival rates. This novel metal-polyphenol nanozyme offers a new strategy for treating flap I/R injury by increasing immune modulation and inhibiting apoptosis.http://www.sciencedirect.com/science/article/pii/S2452199X25002725Copper dihydromyricetinFlapIschemia-reperfusion injuryApoptosisImmune modulation |
| spellingShingle | Xinyu Zhao Shuo Zhang Min Wang Qingrong Li Xiaolong Wei Xu-Lin Chen Xianwen Wang Cu-DHM nanozymes treat flap ischemia-reperfusion injury by amplifying immune modulation in a cascade manner and inhibiting cell apoptosis Bioactive Materials Copper dihydromyricetin Flap Ischemia-reperfusion injury Apoptosis Immune modulation |
| title | Cu-DHM nanozymes treat flap ischemia-reperfusion injury by amplifying immune modulation in a cascade manner and inhibiting cell apoptosis |
| title_full | Cu-DHM nanozymes treat flap ischemia-reperfusion injury by amplifying immune modulation in a cascade manner and inhibiting cell apoptosis |
| title_fullStr | Cu-DHM nanozymes treat flap ischemia-reperfusion injury by amplifying immune modulation in a cascade manner and inhibiting cell apoptosis |
| title_full_unstemmed | Cu-DHM nanozymes treat flap ischemia-reperfusion injury by amplifying immune modulation in a cascade manner and inhibiting cell apoptosis |
| title_short | Cu-DHM nanozymes treat flap ischemia-reperfusion injury by amplifying immune modulation in a cascade manner and inhibiting cell apoptosis |
| title_sort | cu dhm nanozymes treat flap ischemia reperfusion injury by amplifying immune modulation in a cascade manner and inhibiting cell apoptosis |
| topic | Copper dihydromyricetin Flap Ischemia-reperfusion injury Apoptosis Immune modulation |
| url | http://www.sciencedirect.com/science/article/pii/S2452199X25002725 |
| work_keys_str_mv | AT xinyuzhao cudhmnanozymestreatflapischemiareperfusioninjurybyamplifyingimmunemodulationinacascademannerandinhibitingcellapoptosis AT shuozhang cudhmnanozymestreatflapischemiareperfusioninjurybyamplifyingimmunemodulationinacascademannerandinhibitingcellapoptosis AT minwang cudhmnanozymestreatflapischemiareperfusioninjurybyamplifyingimmunemodulationinacascademannerandinhibitingcellapoptosis AT qingrongli cudhmnanozymestreatflapischemiareperfusioninjurybyamplifyingimmunemodulationinacascademannerandinhibitingcellapoptosis AT xiaolongwei cudhmnanozymestreatflapischemiareperfusioninjurybyamplifyingimmunemodulationinacascademannerandinhibitingcellapoptosis AT xulinchen cudhmnanozymestreatflapischemiareperfusioninjurybyamplifyingimmunemodulationinacascademannerandinhibitingcellapoptosis AT xianwenwang cudhmnanozymestreatflapischemiareperfusioninjurybyamplifyingimmunemodulationinacascademannerandinhibitingcellapoptosis |